CASI - CASI Pharmaceuticals EPS misses by $0.01 misses on revenue August, 10 2020 07:10 AM CASI Pharmaceuticals Inc. CASI Pharmaceuticals (NASDAQ:CASI): Q2 GAAP EPS of -$0.09 misses by $0.01.More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...